Cargando…
Lithium Controls Central Nervous System Autoimmunity through Modulation of IFN-γ Signaling
Inhibitors of glycogen synthase kinase 3 (GSK3) are being explored as therapy for chronic inflammatory diseases. We previously demonstrated that the GSK inhibitor lithium is beneficial in experimental autoimmune encephalomyelitis (EAE), the mouse model of multiple sclerosis. In this study we report...
Autores principales: | Rowse, Amber L., Naves, Rodrigo, Cashman, Kevin S., McGuire, Donald J., Mbana, Tethia, Raman, Chander, De Sarno, Patrizia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532311/ https://www.ncbi.nlm.nih.gov/pubmed/23285134 http://dx.doi.org/10.1371/journal.pone.0052658 |
Ejemplares similares
-
Methylprednisolone inhibits IFN-γ and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitis
por: Miljković, Željka, et al.
Publicado: (2009) -
Opposing Roles of Interferon-Gamma on Cells of the Central Nervous System in Autoimmune Neuroinflammation
por: Ottum, Payton A., et al.
Publicado: (2015) -
Paradoxical roles of IFN-γ in models of Th1-mediated autoimmunity
por: Rosloniec, Edward F, et al.
Publicado: (2002) -
Myeloid cells, BAFF, and IFN-γ establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice
por: Scapini, Patrizia, et al.
Publicado: (2010) -
IFN-γ Signaling to Astrocytes Protects from Autoimmune Mediated Neurological Disability
por: Hindinger, Claudia, et al.
Publicado: (2012)